2023-08-22 05:00:03
Home Health
Children will be protected during their first six months of life, explains the American Medicines Agency, thanks to antibodies transmitted by the mother.
Posted on 08/22/2023 07:00 Updated on 08/22/2023 07:27
Reading time: 1 min.
A child hospitalized for bronchiolitis in Bry-sur-Marne (Val-de-Marne), July 6, 2023. (ALINE MORCILLO / HANS LUCAS / AFP)
American health authorities authorized for the first time, on Monday August 21, a vaccine administered to pregnant women with the aim of protecting babies once morest bronchiolitis. This respiratory infection is potentially dangerous, especially for toddlers.
The vaccine from the pharmaceutical giant Pfizer, marketed under the name Abrysvo, targets the respiratory syncytial virus, which can cause pneumonia and bronchiolitis in its most severe forms. The vaccine is licensed for pregnant women between 32 and 36 weeks of gestational age, the US Drug Administration (FDA) said in a statement. The single injection will be made into a muscle.
What regarding Europe?
Children will be protected during their first six months of life thanks to antibodies transmitted by the mother, explains the FDA. This same vaccine had already been approved since May in the United States for people aged 60 and over.
It was also approved in July by the European Medicines Agency – both for babies and for the elderly – but the European Commission must now decide on its marketing authorization within the European Union.
View comments
1692694101
#United #States #authorizes #vaccine #pregnant #women #bronchiolitis #babies
